The breakup between Hims & Hers and Novo Nordisk has hit HIMS stock hard with a 35% crash. Click here for a full investment ...

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Shares in Denmark's pharmaceutical giant Novo Nordisk ( NVO -4.99%) were lower by 4% as of 11 a.m. ET today. The move comes ...

Berger Montague investigates Hims and Hers after stock drops 26% following Novo Nordisk's termination of GLP-1 drug partnership.

General Mills (GIS) stock is under pressure after releasing fourth quarter results that fell short of Wall Street's expectations. Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the ...

A handful of prominent companies on Wall Street have seen some Seeking Alpha analyst activity, including both upgrades and downgrades. Among the group is Hims & Hers (NYSE:HIMS) and Shell (NYSE:SHEL), ...

General Mills (GIS) stock is under pressure after releasing fourth quarter results that fell short of Wall Street's expectations. Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the ...

General Mills (GIS) stock is under pressure after releasing fourth quarter results that fell short of Wall Street's expectations. Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the ...

Nvidia's price target was raised by Loop Capital, which said the chipmaker's market cap could reach $6 trillion. U.S.

The timing is also interesting. GLP-1s are Novo Nordisk's biggest and fastest-growing revenue stream, and competition is heating up. Eli Lilly's Zepbound is gaining traction, compounded access is ...